Natural anticoagulant mechanisms.
作者信息
Rosenberg R D, Rosenberg J S
出版信息
J Clin Invest. 1984 Jul;74(1):1-6. doi: 10.1172/JCI111389.
Abstract
摘要
相似文献
1
Natural anticoagulant mechanisms.天然抗凝机制。
J Clin Invest. 1984 Jul;74(1):1-6. doi: 10.1172/JCI111389.
2
[Anticoagulant protein C system: structure and function].[抗凝血蛋白C系统：结构与功能]
Rev Clin Esp. 1988 Sep;183(4):197-203.
3
The natural anticoagulants.天然抗凝剂。
Clin Haematol. 1986 May;15(2):371-91.
4
5
[Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].[蛋白C、蛋白S与血栓调节蛋白：天然抗血栓形成机制之一]
Rev Invest Clin. 1990 Jan-Mar;42(1):54-62.
6
Hereditary disorders predisposing to thrombosis.易导致血栓形成的遗传性疾病。
Prog Hemost Thromb. 1986;8:71-102.
7
Animal studies of protein C physiology.蛋白质C生理学的动物研究。
Semin Thromb Hemost. 1984 Apr;10(2):149-53. doi: 10.1055/s-2007-1004417.
8
[Anticoagulation protein C: physiological aspects].[抗凝蛋白C：生理方面]
Sangre (Barc). 1985;30(4-C):792-6.
9
[Hemostatic tests for the diagnosis of thrombosis. Endothelial cell function].[用于血栓形成诊断的止血试验。内皮细胞功能]
Rinsho Byori. 1988 Jun;36(6):646-51.
10
[Physiopathology of thrombosis: protein C and thrombomodulin].[血栓形成的病理生理学：蛋白C与血栓调节蛋白]
Nihon Rinsho. 1986 May;44(5):1042-50.
引用本文的文献
1
Electrochemical Monitoring in Anticoagulation Therapy.电化学监测在抗凝治疗中的应用。
Molecules. 2024 Mar 24;29(7):1453. doi: 10.3390/molecules29071453.
2
Crosstalk between the plasminogen/plasmin system and inflammation resolution.纤溶酶原/纤溶酶系统与炎症消退的相互作用。
J Thromb Haemost. 2023 Oct;21(10):2666-2678. doi: 10.1016/j.jtha.2023.07.013. Epub 2023 Jul 24.
3
Investigating protein C and S levels in pregnant women with recurrent early pregnancy loss normal pregnancy.检测复发性早期妊娠丢失正常妊娠孕妇的蛋白 C 和 S 水平。
J Med Life. 2023 Jan;16(1):160-166. doi: 10.25122/jml-2022-0267.
4
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications.抗凝剂：简史、作用机制、药理学和适应证。
Cells. 2022 Oct 13;11(20):3214. doi: 10.3390/cells11203214.
5
Coagulation and complement: Key innate defense participants in a seamless web.凝血与补体：无缝网络中的固有防御关键参与者。
Front Immunol. 2022 Aug 9;13:918775. doi: 10.3389/fimmu.2022.918775. eCollection 2022.
6
Factor IX(a) inhibitors: an updated patent review (2003-present).因子 IX(a)抑制剂：更新的专利审查（2003 年至今）。
Expert Opin Ther Pat. 2022 Apr;32(4):381-400. doi: 10.1080/13543776.2022.2026926. Epub 2022 Jan 17.
7
Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation.人类内皮细胞和成纤维细胞表达和产生凝血酶生成所需的凝血蛋白。
Sci Rep. 2021 Nov 8;11(1):21852. doi: 10.1038/s41598-021-01360-w.
8
Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications.血红素加氧酶-1 调节：COVID-19 及相关并发症的潜在治疗靶点。
Free Radic Biol Med. 2020 Dec;161:263-271. doi: 10.1016/j.freeradbiomed.2020.10.016. Epub 2020 Oct 19.
9
Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release.重组人可溶性血栓调节蛋白通过抑制细胞外组蛋白释放，可减轻脓毒症引起的肾损伤。
PLoS One. 2020 Jan 23;15(1):e0228093. doi: 10.1371/journal.pone.0228093. eCollection 2020.
10
Optical sensing of anticoagulation status: Towards point-of-care coagulation testing.抗凝状态的光学传感：迈向即时凝血检测
PLoS One. 2017 Aug 3;12(8):e0182491. doi: 10.1371/journal.pone.0182491. eCollection 2017.
本文引用的文献
1
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.遗传性抗凝血酶缺乏导致血栓形成倾向。
Thromb Diath Haemorrh. 1965 Jun 15;13:516-30.
2
Preparation and properties of bovine factor VIII (antihemophilic factor).牛因子VIII（抗血友病因子）的制备与特性
Biochemistry. 1980 Feb 5;19(3):401-10. doi: 10.1021/bi00544a001.
3
Abnormal plasminogen, a case of recurrent thrombosis.异常纤溶酶原，一例复发性血栓形成病例。
Thromb Res. 1981;21(4-5):517-22. doi: 10.1016/0049-3848(81)90154-7.
4
Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.抗凝血酶III内皮细胞表面辅因子的体外鉴定。与离体灌注大鼠心脏及牛内皮微载体培养物的平行研究。
J Clin Invest. 1982 Mar;69(3):726-9. doi: 10.1172/jci110502.
5
Isolation and characterization of urokinase from human plasma.从人血浆中分离和鉴定尿激酶
J Biol Chem. 1982 Mar 25;257(6):3276-83.
6
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.鉴定凝血酶催化蛋白C活化的内皮细胞辅因子。
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2249-52. doi: 10.1073/pnas.78.4.2249.
7
8
Circular dichroism spectroscopy of heparin-antithrombin interactions.肝素与抗凝血酶相互作用的圆二色光谱分析
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7190-4. doi: 10.1073/pnas.79.23.7190.
9
Multiple functional domains of the heparin molecule.肝素分子的多个功能域。
Proc Natl Acad Sci U S A. 1981 Feb;78(2):829-33. doi: 10.1073/pnas.78.2.829.
10
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.肝素抗凝血酶结合序列中存在3-O-硫酸化D-葡萄糖胺残基的证据。
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6551-5. doi: 10.1073/pnas.77.11.6551.
Zotero 插件